In This Section

Program: Tuesday, March 2

Sunday, February 28 Monday, March 1 Wednesday, March 3

Tuesday, March 2

Tuesday, March 2

Breakfast

7-8 a.m. | Diamond Ballroom 1-3

Keynote Session 4

8-9:15 a.m. | Diamond Ballroom 5-10

  • 8 a.m. | Keynote Speaker
    Michael Birnbaum, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts
  • 8:25 a.m. | Keynote Speaker
    Tak W. Mak, University of Toronto, Toronto, Ontario, Canada
  • 8:50 a.m. | Discussion / Q&A

Break

9:15-9:30 a.m. | Diamond Ballroom Foyer

Major Symposia 5-6

9:30-11 a.m.

Major Symposium 5: Measuring TCR Recognition of Antigen at Scale

Diamond Ballroom 5-10
Session Chair: Ton N. Schumacher, Netherlands Cancer Institute, Amsterdam, Netherlands

  • 9:30 a.m. | Speaker to be announced
  • 9:50 a.m. | Dirk Busch, Technical University of Munich, Germany
  • 10:10 a.m | Large-scale priming of T cells for parallel identification of TCR-pMHC pairs
    Johanna Olweus, Oslo University Hospital, Norway
  • 10:30 a.m. | Discussion / Q&A

Major Symposium 6: Mechanisms of Response and Resistance – Towards More Effective Immunotherapies

Diamond Ballroom 4

Break

11-11:15 a.m. | Diamond Ballroom Foyer

Spotlight on Proffered Papers Sessions 3-4

11:15 a.m.-12 p.m.

Proffered Papers Session 3

Diamond Ballroom 5-10
Session Chair: Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, New York

Proffered Papers Session 4

Diamond Ballroom 4
Session Chair: Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

Poster Session C / Exhibit Show / Lunch

12-2:45 p.m. | Platinum Ballroom

Major Symposia 7-8

3-4:30 p.m.

Major Symposium 7: Beyond Conventional Cell Therapy – Emerging Technologies for Precision Immunotherapy

Diamond Ballroom 5-10
Session Chair: Justin Eyquem, University of California, San Francisco, California

  • 3 p.m. | Justin Eyquem
  • 3:20 p.m. | Speaker to be announced
  • 3:40 p.m. | Speaker to be announced
  • 4 p.m. | Discussion / Q&A

Major Symposium 8: New Advances in TIL Therapy             

Diamond Ballroom 4
Session Chair: James C. Yang, National Cancer Institute, Bethesda, Maryland

  • 3 p.m. | James C. Yang
  • 3:20 p.m. | Speaker to be announced
  • 3:40 p.m. | Speaker to be announced
  • 4 p.m. | Discussion / Q&A

Break

4:30-4:45 p.m. | Diamond Ballroom Foyer

Spotlight Sessions 1-2

4:45-5:40 p.m.

Spotlight Session 1: Generative Design of Immune Receptors / Protein Design

Diamond Ballroom 5-10

Spotlight Session 2: Precision Targets for Solid Tumors: Neoantigens, Fusion-Driven Antigens, and the Dark Genome

Diamond Ballroom 4
Session Chair: Bernard A. Fox, Earle A Chiles Research Institute, Renton, Washington

  • 4:45 p.m. | Bernard A. Fox
  • 5:05 p.m. | Speaker to be announced
  • 5:25 p.m. | Discussion / Q&A

Spotlight Sessions 3-4

5:45-6:40 p.m.

Spotlight Session 3: Immune Cell Interactions in the TME / The Myeloid–Stromal Connection in Tumor Immunity and Therapy Resistance

Diamond Ballroom 5-10
Session Chair: Daniel Peeper, Netherlands Cancer Institute, Amsterdam, The Netherlands

  • 5:45 p.m. | Daniel Peeper
  • 6:05 p.m. | Amanda Lund, NYU Grossman School of Medicine, New York, New York
  • 6:25 p.m. | Discussion / Q&A

Spotlight Session 4: Non-MHC-Restricted Anti-Tumour Immunity

Diamond Ballroom 4
Session Chair: Adrian Hayday, The Francis Crick Institute, London, United Kingdom

  • 5:45 p.m. | Adrian Hayday
  • 6:05 p.m. | Speaker to be announced
  • 6:25 p.m. | Discussion / Q&A

Evening off / Dinner on own

6:40 p.m.